Citigroup’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-30
Closed 7774
2020
Q2
$0 Hold
30
﹤0.01% 7877
2020
Q1
$0 Hold
30
﹤0.01% 7975
2019
Q4
$0 Sell
30
-1,155
-97% -$3.23K ﹤0.01% 7975
2019
Q3
$5K Sell
1,185
-3,990
-77% -$23.2K ﹤0.01% 7374
2019
Q2
$37K Buy
5,175
+2,376
+85% +$16.2K ﹤0.01% 6733
2019
Q1
$19K Sell
2,799
-2,346
-46% -$15.5K ﹤0.01% 7002
2018
Q4
$37K Buy
5,145
+3,788
+279% +$42.2K ﹤0.01% 6484
2018
Q3
$26K Buy
1,357
+1,327
+4,423% +$47.4K ﹤0.01% 6968
2018
Q2
$2K Sell
30
-42
-58% -$2.13K ﹤0.01% 7498
2018
Q1
$3K Sell
72
-28
-28% -$1.2K ﹤0.01% 7330
2017
Q4
$5K Buy
100
+44
+79% +$2.32K ﹤0.01% 7254
2017
Q3
$2K Sell
56
-236
-81% -$10.8K ﹤0.01% 7073
2017
Q2
$14K Sell
292
-307
-51% -$18.1K ﹤0.01% 6435
2017
Q1
$43K Sell
599
-4,023
-87% -$266K ﹤0.01% 5805
2016
Q4
$264K Buy
4,622
+3,908
+547% +$358K ﹤0.01% 5053
2016
Q3
$91K Buy
714
+45
+7% +$5.76K ﹤0.01% 5269
2016
Q2
$83K Sell
669
-4,476
-87% -$515K ﹤0.01% 5236
2016
Q1
$430K Buy
5,145
+5,074
+7,146% +$418K ﹤0.01% 4287
2015
Q4
$6K Buy
71
+5
+8% +$536 ﹤0.01% 7004
2015
Q3
$8K Sell
66
-465
-88% -$63.1K ﹤0.01% 6574
2015
Q2
$81K Buy
531
+423
+392% +$69.8K ﹤0.01% 5175
2015
Q1
$19K Sell
108
-382
-78% -$57.9K ﹤0.01% 6129
2014
Q4
$75K Sell
490
-231
-32% -$28.8K ﹤0.01% 5429
2014
Q3
$77K Buy
721
+592
+459% +$82.5K ﹤0.01% 4979
2014
Q2
$20K Sell
129
-15
-10% -$2K ﹤0.01% 5811
2014
Q1
$19K Buy
144
+133
+1,209% +$20.7K ﹤0.01% 6067
2013
Q4
$2K Sell
11
-2
-15% -$344 ﹤0.01% 6807
2013
Q3
$2K Sell
13
-4
-24% -$630 ﹤0.01% 6620
2013
Q2
$2K Buy
+17
New +$2.4K ﹤0.01% 6554

Other funds holding ELGX

Citigroup's ELGX Position: Q3 2020 in Review

Citigroup sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 30 shares.

Citigroup first reported a position in ELGX in Q2 2013 and held it in 29 quarters. The position peaked at $430K in Q1 2016. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • Citigroup reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • Citigroup sold 30 Endologix Inc shares in Q3 2020.
  • Citigroup first reported a position in Endologix Inc in Q2 2013 and held it in 29 quarters.
  • Citigroup's Endologix Inc position peaked at $430K in Q1 2016.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on Citigroup's 13F filing for Q3 2020, filed 12 Nov 2020.